Home / Products / Cancer (Tumor) Cell Lines / NCI-H1792
NCI-H1792
Datasheet Protocol

NCI-H1792

Cat. No. ARC0589
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Lung

Growth Properties:

Adherent

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

NCI-H1792 is a cancer cell line of lung adenocarcinoma, isolated from metastatic; pleural effusion.
 
Synonym: H1792; H-1792; NCIH1792

Recommended Products

MPC2 Knockout HT29 Polyclonal Cells MPC2 Knockout HT29 Polyclonal Cells Cat. No. ARG14384 CSDE1 Knockout 143B Polyclonal Cells CSDE1 Knockout 143B Polyclonal Cells Cat. No. ARG11937 AKT3 Knockout THP-1 Polyclonal Cells AKT3 Knockout THP-1 Polyclonal Cells Cat. No. ARG23456 ATG2B Knockout NCI-H1975 Polyclonal Cells ATG2B Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG31241 CASP3 Knockout HT29 Polyclonal Cells CASP3 Knockout HT29 Polyclonal Cells Cat. No. ARG42442 MPP7 Knockout Raji Polyclonal Cells MPP7 Knockout Raji Polyclonal Cells Cat. No. ARG1321
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Lung
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
50 years
Sex of Donor:
Male
Derived From Site:
Metastatic; Pleural effusion
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CRADD Knockout HT29 Polyclonal Cells

CRADD Knockout HT29 Polyclonal Cells

Cat. No. ARG14100
 CNTROB Knockout A549 Polyclonal Cells

CNTROB Knockout A549 Polyclonal Cells

Cat. No. ARG10188
 BAX Knockout 786-O Polyclonal Cells

BAX Knockout 786-O Polyclonal Cells

Cat. No. ARG25062
 ASGR1 Knockout KYSE30 Polyclonal Cells

ASGR1 Knockout KYSE30 Polyclonal Cells

Cat. No. ARG36283
 ERGIC1 Knockout MES-OV Polyclonal Cells

ERGIC1 Knockout MES-OV Polyclonal Cells

Cat. No. ARG6554
 EML3 Knockout HEK293T Polyclonal Cells

EML3 Knockout HEK293T Polyclonal Cells

Cat. No. ARG3930